Your browser doesn't support javascript.
loading
Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART).
Strowitzki, Thomas; Kuczynski, Waldemar; Mueller, Arnd; Bias, Peter.
Afiliação
  • Strowitzki T; Department of Gynecological Endocrinology and Reproductive Medicine, University of Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany. thomas_strowitzki@med.uni-heidelberg.de.
  • Kuczynski W; Centre for Reproductive Medicine, Cryobank, 15879, Bialystok, Poland. kuczynski@umb.edu.pl.
  • Mueller A; Department of Gynaecology and Gynaecological Oncology, Medical University, 15089, Bialystok, Poland. kuczynski@umb.edu.pl.
  • Bias P; Merckle GmbH, A Member of The Teva Group, 89079, Ulm, Germany. Arnd.Mueller@ratiopharm.de.
Reprod Biol Endocrinol ; 14: 1, 2016 Jan 06.
Article em En | MEDLINE | ID: mdl-26733057
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2016 Tipo de documento: Article